Table 2.
Mass spectrometer parameters for the determination of target analytes
| Nº | Compound | Precursor ion (m/z) | Capillary voltage (Ion mode) | Quantification ion, m/z (collision potential, V) | Quantification ion, m/z (collision potential, V) |
|---|---|---|---|---|---|
| 1 | Naproxen | 231.2 | 36 (ESI +) | 153.1 (28.5) | 170.0 (22.0) |
| 2 | Carbamazepine | 237.1 | 40 (ESI +) | 194.0 (13.5) | 192.0 (17.0) |
| 3 | Ketoprofen | 255.1 | 52 (ESI +) | 209.0 (10.0) | 104.9 (18.5) |
| 4 | Bezafibrate | 359.8 | 64 (ESI -) | 273.7 (15.5) | 153.5 (28.5) |
| 5 | Atenolol | 267.0 | 52 (ESI +) | 145.0 (23.5) | 190.0 (16.5) |
| 6 | Metamizole | 218.0 | 30 (ESI +) | 56.0 (12.5) | 97.0 (11.5) |
| 7 | Paraxanthine | 181.0 | 40 (ESI +) | 124.0 (17.0) | |
| 8 | Fluoxetine | 310.0 | 30 (ESI +) | 44.0 (6.5) | 148.0 (5.5) |
| 9 | Levofloxacin | 362.3 | 40 (ESI +) | 318.3 (20.0) | 261.2 (30.0) |
| 10 | Norfloxacin | 320.3 | 40 (ESI +) | 302.3 (20.0) | 276.2 (15.0) |
| 11 | Ciprofloxacin | 332.3 | 40 (ESI +) | 314.3 (22.0) | 288.2 (18.0) |
| 12 | Enrofloxacin | 360.3 | 40 (ESI +) | 316.3 (20.0) | 245.3 (25.0) |
| 13 | Sarafloxacin | 386.3 | 40 (ESI +) | 368.3 (20.0) | 299.2 (30.0) |